CD38 and infection: No treatment-related infections were reported throughout the study, although the risk of hypogammaglobulinemia has been raised as a concern with anti-CD38 therapy due to CD38 being expressed in normal plasma cells, and as seen with the nonspecific elimination of IgG and IgM (Figure 2).22,23